Endocrine Journal
Online ISSN : 1348-4540
Print ISSN : 0918-8959
ISSN-L : 0918-8959
NOTES
Adrenocorticotropic Hormone and 17-Hydroxyprogesterone Levels during High-dose Glucocorticoid Supplement for the Management of Clitoroplasty of CYP21A2 Deficiency
Yasuhiro NAIKI, Kenji NANAO, Yukihiro HASEGAWA
Author information
JOURNAL FREE ACCESS

2004 Volume 51 Issue 3 Pages 367-373

Details
Abstract
ACTH and 17-hydroxyprogesterone (17OHP) levels during clitoro- and labinoplasty for CYP21A2 deficiency have not been reported. In this study, we measured these levels during surgery. Intensive glucocorticoid supplement (IGS Tx; intravenous bolus injection of daily dose (14.6 to 22.2 mg/m2) of hydrocortisone followed by continuous infusion of three times the daily dose for 24 hours) was done to eight patients for surgery. ACTH and 17OHP levels were generally suppressed during operation by this protocol, but mid-surgical elevations of ACTH and 17OHP levels were observed in four out of the eight. In another three patients than the eight as described, oral dexamethasone pretreatment (1 mg/m2) was administered for two days before surgery in addition to IGS Tx. ACTH and 17OHP levels were completely suppressed throughout operation, indicating that this kind of additional pretreatment is more effective approach.
Content from these authors
© The Japan Endocrine Society
Previous article Next article
feedback
Top